Rawlins John, Din Jehangir N, Talwar Suneel, O'Kane Peter
Dorset Heart Centre, Royal Bournemouth Hospital, Bournemouth, UK.
Interv Cardiol. 2016 May;11(1):27-32. doi: 10.15420/icr.2016:2:2.
Excimer laser coronary atherectomy (ELCA) is a long-established adjunctive therapy that can be applied during percutaneous coronary intervention (PCI). Technical aspects have evolved and there is an established safety and efficacy record across a number of clinical indications in contemporary interventional practice where complex lesions are routinely encountered. The role of ELCA during PCI for thrombus, non-crossable or non-expandable lesions, chronic occlusions and stent under-expansion are discussed in this review. The key advantage of ELCA over alternative atherectomy interventions is delivery on a standard 0.014-inch guidewire. Additionally, the technique can be mastered by any operator after a short period of training. The major limitation is presence of heavy calcification although when rotational atherectomy (RA) is required but cannot be applied due to inability to deliver the dedicated RotaWire (Boston Scientific), ELCA can create an upstream channel to permit RotaWire passage and complete the case with RA - the RASER technique.
准分子激光冠状动脉斑块切除术(ELCA)是一种长期使用的辅助治疗方法,可在经皮冠状动脉介入治疗(PCI)期间应用。技术层面已经有所发展,在当代介入实践中,对于经常遇到的复杂病变,在多个临床适应症方面都有既定的安全性和有效性记录。本文综述了ELCA在PCI治疗血栓、不可通过或不可扩张病变、慢性闭塞和支架扩张不足时的作用。ELCA相对于其他斑块切除术的关键优势在于可通过标准的0.014英寸导丝进行操作。此外,经过短时间培训后,任何操作者都能掌握该技术。主要局限性是存在重度钙化,不过当需要旋磨术(RA)但由于无法置入专用的旋磨导丝(波士顿科学公司)而不能应用时,ELCA可以创建一个上游通道以允许旋磨导丝通过,并用RA完成手术——即RASER技术。